Table 1.
Summary of potential toxic effects of micro- and nanoplastics on human health.
| Toxic Effects | Characteristics of Plastic Particles | Particle Size | Details | References |
|---|---|---|---|---|
| Inflammation | Polystyrene particles | 202 nm and 535 nm |
|
[112] |
| Unaltered/Carboxylated polystyrene nanoparticles | 20 nm, 44 nm, 500 nm, and 1000 nm |
|
[113,114] | |
| Carboxylated and amino-modified polystyrene particles | 120 nm |
|
[115] | |
| Unaltered polyethylene particles | 0.3 μm, 10 μm |
|
[117] | |
| Polyethylene particles from plastic prosthetic implants | 0.2 μm and 10 μm |
|
[121] | |
|
[121,122,123] | |||
| Polystyrene microplastics particles | 5 μm and 20 μm |
|
[125] | |
| Oxidative stress and apoptosis | Amine-modified polystyrene nanoparticles | 60 nm |
|
[126] |
| Cationic polystyrene nanoparticles | 60 nm |
|
[127,128] | |
| Unaltered or functionalized polystyrene | 20 nm, 40 nm, 50 nm, and 100 nm |
|
[129,130,131,132] | |
| polyvinyl chloride (PVC) and poly (methyl methacrylate) (PMMA) | 120 nm, 140 nm |
|
[133] | |
| Metabolic homeostasis | Pristine and fluorescent polystyrene microplastics | 5 µm |
|
[134,135] |
| Anionic carboxylated polystyrene nanoparticles | 20 nm |
|
[136] | |
| Polystyrene nanoparticles | 30 nm |
|
[137] | |
| Cationic polystyrene nanoparticles | 50 nm and 200 nm |
|
[138] | |
| Pristine polystyrene microparticles | 5 µm and 20 µm |
|
[125,139,140] | |
| Microplastics | 0.5 µm and 5 µm |
|
[135,141] |